TABLE 3.
Comparative yield of clinically important isolates in FN versus SN anaerobic blood culture bottles from patients on antimicrobial therapy
| Microorganism | No. of isolates detected by:
|
P value | ||
|---|---|---|---|---|
| Both bottles | FN only | SN only | ||
| Gram-positive bacteria | ||||
| Staphylococcus aureus | 72 | 140 | 6 | <0.001 |
| Coagulase-negative staphylococci | 45 | 24 | 16 | NSa |
| Streptococcus spp.b | 8 | 2 | 2 | NS |
| Enterococcus spp.c | 38 | 13 | 7 | NS |
| Bacillus sp. | 0 | 1 | 0 | NS |
| Gram-negative bacilli | ||||
| Enterobacteriaceaed | 35 | 25 | 7 | <0.005 |
| Other gram-negative bacillie | 4 | 1 | 8 | <0.05 |
| Anaerobic bacteriaf | 2 | 7 | 2 | NS |
| Yeastsg | 0 | 0 | 6 | <0.05 |
| All microorganisms | 204 | 213 | 54 | <0.001 |
NS, not significant (P > 0.05).
Includes five isolates of Streptococcus pneumoniae, four of Streptococcus pyogenes, two of viridans group streptococci, and one of Streptococcus agalactiae.
Includes 47 of Enterococcus faecalis, 10 of Enterococcus faecium, and 1 of Enterococcus sp.
Includes 23 of Klebsiella pneumoniae; 16 of Escherichia coli; 8 of E. cloacae; 7 of Salmonella spp.; 3 of Enterobacter aerogenes; 3 of Klebsiella oxytoca; 3 of Serratia marcescens; and 1 each of Ewingella americana, Morganella morganii, Providencia stuartii, and Serratia liquefaciens.
Includes 10 of P. aeruginosa, 1 of A. baumannii, 1 of Oligella sp., and 1 of Haemophilus influenzae.
Includes three of Bacteroides fragilis; three of Clostridium clostridioforme; two of the Bacteroides fragilis group; and one each of Clostridium difficile, Clostridium ramosum, and Bacteroides distasonis.
Includes two of Candida glabrata, two of C. parapsilosis, and one each of Candida albicans and Candida tropicalis.